Melanoma Cancer Immunotherapy Using PD-L1 siRNA and Imatinib Promotes Cancer-Immunity Cycle
Chenyang Li, Xiuping Han
Topics & Concepts
Cancer researchCytotoxic T cellPI3K/AKT/mTOR pathwayCell cycleCancerApoptosisBiologyCarcinogenesisCancer cellImmune checkpointImmune systemImmunotherapyImmunologyIn vitroBiochemistryGeneticsImmunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersCancer Research and Treatments